描述
Bile acid metabolism modulation by gut microbiota and probiotic interventions, relevant to cholesterol regulation and NAFLD prevention. Primary and secondary bile acid conversion pathways are outlined.
Figure 12
DiagramSource Paper
Gut Microbiota-Targeted Therapeutics for Metabolic Disorders: Mechanistic Insights into the Synergy of Probiotic-Fermented Herbal Bioactives.Cite This Figure
![Figure 12: Bile acid metabolism modulation by gut microbiota and probiotic interventions, relevant to cholesterol regulation and NAFLD prevention. Primary and secondary bile acid conversion pathways are outlined.]() > Source: Yue Fan et al. "Gut Microbiota-Targeted Therapeutics for Metabolic Disorders: Mechanistic Insigh." *International journal of molecular sciences*, 2025. PMID: [40564947](https://pubmed.ncbi.nlm.nih.gov/40564947/)
<figure> <img src="" alt="Bile acid metabolism modulation by gut microbiota and probiotic interventions, relevant to cholesterol regulation and NAFLD prevention. Primary and secondary bile acid conversion pathways are outlined." /> <figcaption>Figure 12. Bile acid metabolism modulation by gut microbiota and probiotic interventions, relevant to cholesterol regulation and NAFLD prevention. Primary and secondary bile acid conversion pathways are outlined.<br> Source: Yue Fan et al. "Gut Microbiota-Targeted Therapeutics for Metabolic Disorders: Mechanistic Insigh." <em>International journal of molecular sciences</em>, 2025. PMID: <a href="https://pubmed.ncbi.nlm.nih.gov/40564947/">40564947</a></figcaption> </figure>